GGrantIndex
Sort

11,323 grants matching glioblastoma

Predicting brain tumor progression via multiparametric image analysis and modelin

$541,169
Christos Davatzikos · University Of Pennsylvania · R01 · FY2015 · NS

Targeting Tumors with NF1 Loss

$541,146
Yolanda Sanchez · Dartmouth College · R01 · FY2018 · NS

Targeting Malignant Reprogramming of Glioblastoma Stem Cells Through Dual Inhibition of S6K1 and BIRC3

$541,074
Arnold Etame · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · NS

Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform

$540,860
Albert Folch · University Of Washington · R01 · FY2021 · CA

Molecular Mechanisms of Drug Resistance in Primary Brain Tumors

$540,855
Ingo K Mellinghoff · Sloan-Kettering Inst Can Research · R35 · FY2025 · NS

Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model

$540,797
Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2020 · CA

Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model

$540,797
Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2021 · CA

Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy

$540,614
David Reardon · Brigham And Women'S Hospital · P01 · FY2021 · CA

Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients

$540,401
John K. Wiencke · University Of California, San Francisco · P50 · FY2020 · CA

Allergic Condition Susceptibility Polymorphisms and Glioma Risk

$540,339
Judith Schwartzbaum · Ohio State University · R01 · FY2010 · CA

Influence of Anti-Angiogenic Therapy on Drug Delivery to Brain Tumors

$540,310
William F Elmquist · University Of Minnesota · R01 · FY2012 · NS

Developing new therapeutic strategies for brain metastasis

$540,115
Eva Hernando · New York University School Of Medicine · R01 · FY2023 · CA

Understanding EGF receptor activation by growth factors and oncogenic mutations

$539,744
Mark A. Lemmon · Yale University · R01 · FY2021 · CA

Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment

$539,533
Alexander V Ljubimov · Cedars-Sinai Medical Center · R01 · FY2025 · CA

Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform

$539,424
Albert Folch · University Of Washington · R01 · FY2025 · CA

Genome wide profiling of histone variants in tumors

$539,022
Yamini P Dalal · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1

$538,908
Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Targeting Glioblastoma Using Novel Small Molecule HIF-1 Pathway Inhibitors

$538,885
Erwin G Van Meir · Emory University · R01 · FY2010 · CA

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

$538,522
William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Predicting brain tumor progression via multiparametric image analysis and modelin

$538,156
Christos Davatzikos · University Of Pennsylvania · R01 · FY2016 · NS

Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier

$538,027
Jonathan A Winger · Omniox, Inc. · R01 · FY2021 · CA

Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field

$537,636
Wei Chen · University Of Minnesota · R01 · FY2019 · CA

Evaluating microtubule binding as a potential imaging biomarker for Alzheimer's disease

$537,570
Kiran Solingapuram Sai · Wake Forest University Health Sciences · R01 · FY2024 · AG

Mammalian models for integrated metabolic and molecular profiling of malignant glioma

$537,485
David A. Nathanson · University Of California Los Angeles · R01 · FY2019 · CA

Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies

$537,395
Yoshihiro Izumiya · University Of California At Davis · R01 · FY2019 · CA